Nicole J. Corbin-Stein

Nicole J. Corbin-Stein

Auto-generated profile, based on publicly available information

Nicole J. Corbin-Stein

University of Alabama at Birmingham, Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ASA. M. Schonhoff
A. M. Schonhoff
DFD. A. Figge
D. A. Figge
GWG. P. Williams
G. P. Williams
AJA. Jurkuvenaite
A. Jurkuvenaite
NGN. J. Gallups
N. J. Gallups
AHA. S. Harms
A. S. Harms
Dopaminergic cell loss due to the accumulation of α-syn is a core feature of the pathogenesis of Parkinson disease. Neuroinflammation specifically induced by α-synuclein has been shown to exacerbate neurodegeneration, yet the role of central nervous system (CNS) resident macrophages in this process remains unclear. We found that a specific subset of CNS resident macrophages, border-associated macrophages (BAMs), play an essential role in mediating α-synuclein related neuroinflammation due to their unique role as the antigen presenting cells necessary to initiate a CD4 T cell response whereas the loss of MHCII antigen presentation on microglia had no effect on neuroinflammation. Furthermore, α-synuclein expression led to an expansion in border-associated macrophage numbers and a unique damage-associated activation state. Through a combinatorial approach of single-cell RNA sequencing and depletion experiments, we found that border-associated macrophages played an essential role in immune cell recruitment, infiltration, and antigen presentation. Furthermore, border-associated macrophages were identified in post-mortem PD brain in close proximity to T cells. These results point to a role for border-associated macrophages in mediating the pathogenesis of Parkinson disease through their role in the orchestration of the α-synuclein-mediated neuroinflammatory response.

13 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JWJhodi M. Webster
Jhodi M. Webster
YYYa-Ting Yang
Ya-Ting Yang
AMAidan T. Miller
Aidan T. Miller
AZAsta Zane
Asta Zane
KSKasandra Scholz
Kasandra Scholz
JMJeremy Molina
Jeremy Molina
Alzheimer’s (AD) and Parkinson disease (PD) pathology often co-occur. Amyloid-β and phosphorylated tau are found in 30-50% of idiopathic PD cases, while α-synuclein inclusions are present in 50% of AD cases. These co-pathologies are linked to increased mortality and earlier onset of cognitive decline. Immune activation is a hallmark of these neurodegenerative diseases, but current models primarily examine each pathology in isolation. How these co-pathologies drive inflammation and neuronal loss remains poorly understood. We therefore developed a mouse model combining tau, amyloid-β, and α-synuclein. We found that co-pathologies synergistically trigger an amplified neuroimmune response, with expanded populations of CD4 + and CD8 + tissue-resident memory T cells and CD68 + microglia, compared to single pathologies. These changes were abundant in the hippocampus and cortex, regions with elevated protein pathology load and enhanced neuronal loss. Our findings demonstrate that co-pathologies enhance proteinopathy and synergistically enhance immune activation and neurodegeneration, suggesting that combinatorial therapeutic strategies that target both co-pathologies and inflammation, may be disease modifying. Summary: Webster et al. demonstrate that co-occurring Alzheimer’s and Parkinson disease protein pathologies, common in cognitively impaired patient populations, amplify proteinopathy and synergistically enhance CNS neuroinflammatory responses and neurodegeneration. This work supports the need for combinatorial therapeutic strategies and positions neuroinflammation as an important link for co-pathology enhanced neurodegeneration.

3 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NCNicole J. Corbin-Stein
Nicole J. Corbin-Stein
GCGabrielle M. Childers
Gabrielle M. Childers
JWJhodi M. Webster
Jhodi M. Webster
AZAsta Zane
Asta Zane
YYYa-Ting Yang
Ya-Ting Yang
AHAshley S. Harms
Ashley S. Harms
Multiple system atrophy (MSA) is rare, fast progressing, and fatal synucleinopathy with alpha-synuclein (α-syn) inclusions located within oligodendroglia called glial cytoplasmic inclusions (GCI). Along with GCI pathology there is severe demyelination, neurodegeneration, and neuroinflammation. In post-mortem tissue, there is significant infiltration of CD8+ T cells into the brain parenchyma, however their role in disease progression is unknown. To determine the role of CD8+ T cells, a modified AAV, Olig001-SYN, was used to selectively overexpress α-syn in oligodendrocytes modeling MSA in mice. Four weeks post transduction, we observed significant CD8+ T cell infiltration into the striatum of Olig001-SYN transduced mice recapitulating the CD8+ T cell infiltration observed in post-mortem tissue. To understand the role of CD8+ T cells, a CD8 knockout mice were transduced with Olig001-SYN. Six months post transduction into a mouse lacking CD8+ T cells, demyelination and neurodegeneration were unchanged. Four weeks post transduction, neuroinflammation and demyelination were enhanced in CD8 knockout mice compared to wild type controls. Applying unbiased spectral flow cytometry, CD103+, CD69+, CD44+, CXCR6+, CD8+ T cells were identified when α-syn was present in oligodendrocytes, suggesting the presence of tissue resident memory CD8+ T (Trm) cells during MSA disease progression. This study indicates that CD8+ T cells are not critical in driving MSA pathology but are needed to modulate the neuroinflammation and demyelination response.

13 October 2023
Verified
Preprint
Open access
PDF file
AZAsta Zane
Asta Zane
NCNicole J Corbin-Stein
Nicole J Corbin-Stein
GCGabrielle Childers
Gabrielle Childers
JWJhodi Webster
Jhodi Webster
VYVickie Yang
Vickie Yang
AHAshley Harms
Ashley Harms
This protocol allows for stereotaxic surgeries to administer unilateral or bilateral injections of small volumes of viral vectors or other suspensions into the mouse parenchyma. After using an anesthesia chamber to put the mouse to sleep, it is then placed and stabilized on the stereotaxic frame and is prepared for surgery. The mouse's bregma coordinates is used to calculate the appropriate coordinates needed to inject into specific brain regions.This protocol is optimized for differentbrain regions based on the coordinates listed in the guidelines.

3 November 2023
Verified
Preprint
Open access
PDF file
AZAsta Zane
Asta Zane
NCNicole J Corbin-Stein
Nicole J Corbin-Stein
GCGabrielle Childers
Gabrielle Childers
JWJhodi Webster
Jhodi Webster
VYVickie Yang
Vickie Yang
AHAshley Harms
Ashley Harms
This protocol outlines the procedure to ethically euthanize/sacrifice a mouse using sterile, cold PBS and paraformaldehyde (4%). Following this perfusion, organs including the brain can be retrieved and fixed for further experiments.

3 November 2023
Verified
Preprint
Open access
PDF file
AZAsta Zane
Asta Zane
NCNicole J Corbin-Stein
Nicole J Corbin-Stein
GCGabrielle Childers
Gabrielle Childers
JWJhodi Webster
Jhodi Webster
VYVickie Yang
Vickie Yang
AHAshley Harms
Ashley Harms
This protocol highlights sectioning 40 micron mouse brain tissue to be used for histology experiments.